» Articles » PMID: 33112569

Liquid Nitrogen-Based Cryoablation in In Vivo Porcine Tissue: A Pilot Study

Overview
Specialty Oncology
Date 2020 Oct 28
PMID 33112569
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Liquid nitrogen-based cryoablation induces freezing evenly throughout the probe tip surface, resulting in larger ablation volumes and faster treatment times. The purpose of this preliminary investigation is to determine the efficacy of the liquid nitrogen-based Visica2 Cryoablation System (Sanarus Technologies, Pleasanton, CA) in in vivo porcine kidney, liver, and fibro-fatty tissue.

Methods: Ablations were performed under ultrasound guidance in 4 Yorkshire pigs. The target lesion cross-section width (W) and depth (D) were 1 cm for liver (n=8), kidney (n=4), and head-neck (n=5) and 2 cm for kidney (n=4).  Expected axial length (L) of the resulting lesion is approximately 4 cm.  After three-day survival, the ablated tissue was harvested and histologically analysed. The mean width and depth were compared with the target diameter using a one-sample t-test.

Results: All animals survived the procedure. For the 1 cm target, mean dimensions (L x W x D) were 3.8±1.5 x 1.7±0.3 x 1.7±0.7 for liver, 3.0±0.5 x 2.0±0.4 x 1.7±0.6 for kidney, and 3.3±0.8 x 1.8±0.4 x 1.8±0.4 for head-neck.  Mean width and depth were significantly greater than desired dimension.  For the 2 cm target, mean dimensions were 3.2±0.5 x 3.1±0.8 x 1.9±0.7.  Mean width and depth were not significantly different to desired target.

Conclusion: Our preliminary results show that the Visica2 liquid nitrogen-based cryoablation system can efficiently and reproducibly create ablation volumes in liver, kidney, and fibro-fatty tissue within 4 minutes and 12 minutes for 1cm and 2cm targeted diameters, respectively. Further investigation is necessary to determine the optimal freeze-thaw-freeze protocol for larger ablation volumes.<br />.

Citing Articles

Liquid nitrogen-based cryoablation: complication rates for lung, bone, and soft tissue tumors cryoablation.

Orsi F, Hamiddin A, Sattin C, Pizzi C, Varano G, Della Vigna P Br J Radiol. 2024; 97(1163):1863-1869.

PMID: 39226178 PMC: 11491613. DOI: 10.1093/bjr/tqae171.


CT-Guided Percutaneous Cryoablation of Breast Cancer: A Single-Center Experience.

Vogl T, Bielfeldt J, Kubler U, Adwan H Cancers (Basel). 2024; 16(13).

PMID: 39001435 PMC: 11240795. DOI: 10.3390/cancers16132373.


Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies.

Bazeed A, Day C, Garg S Cancers (Basel). 2022; 14(17).

PMID: 36077794 PMC: 9454856. DOI: 10.3390/cancers14174257.

References
1.
Lv Y, Jin Y, Yan Q, Yuan D, Wang Y, Li X . The value of 64-slice spiral CT perfusion imaging in the treatment of liver cancer with argon-helium cryoablation. Oncol Lett. 2017; 12(6):4584-4588. PMC: 5228367. DOI: 10.3892/ol.2016.5241. View

2.
Kawamura M, Izumi Y, Tsukada N, Asakura K, Sugiura H, Yashiro H . Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006; 131(5):1007-13. DOI: 10.1016/j.jtcvs.2005.12.051. View

3.
Jacob G, Kurzer M, Fuller B . An assessment of tumor cell viability after in vitro freezing. Cryobiology. 1985; 22(5):417-26. DOI: 10.1016/0011-2240(85)90152-x. View

4.
Hewitt P, Zhao J, Akhter J, Morris D . A comparative laboratory study of liquid nitrogen and argon gas cryosurgery systems. Cryobiology. 1998; 35(4):303-8. DOI: 10.1006/cryo.1997.2039. View

5.
Poplack S, Levine G, Henry L, Wells W, Heinemann F, Hanna C . A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical Resection. AJR Am J Roentgenol. 2015; 204(5):1100-8. PMC: 4836389. DOI: 10.2214/AJR.13.12325. View